OFATUMUMAB for Chronic lymphocytic leukaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,216 adverse event reports in the FDA FAERS database where OFATUMUMAB was used for Chronic lymphocytic leukaemia.
Most Reported Side Effects for OFATUMUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 5,202 | 17.4% | 8 | 361 |
| Headache | 4,430 | 14.8% | 6 | 300 |
| Pain | 3,382 | 11.3% | 2 | 243 |
| Chills | 3,372 | 11.3% | 2 | 176 |
| Pyrexia | 3,370 | 11.3% | 31 | 436 |
| Influenza like illness | 2,727 | 9.1% | 2 | 149 |
| Nausea | 1,688 | 5.6% | 6 | 160 |
| Multiple sclerosis relapse | 1,525 | 5.1% | 2 | 361 |
| Covid-19 | 1,435 | 4.8% | 12 | 254 |
| Asthenia | 1,393 | 4.7% | 9 | 198 |
| Gait disturbance | 1,342 | 4.5% | 2 | 201 |
| Hypoaesthesia | 1,316 | 4.4% | 0 | 167 |
| Feeling abnormal | 1,306 | 4.4% | 2 | 112 |
| Multiple sclerosis | 1,267 | 4.2% | 6 | 131 |
| Malaise | 1,243 | 4.2% | 10 | 171 |
Other Indications for OFATUMUMAB
Multiple sclerosis (11,816)
Product used for unknown indication (9,779)
Relapsing-remitting multiple sclerosis (3,864)
Relapsing multiple sclerosis (3,705)
Secondary progressive multiple sclerosis (1,099)
Clinically isolated syndrome (1,075)
Multiple sclerosis relapse (158)
Mantle cell lymphoma (143)
Marginal zone lymphoma (131)
Central nervous system lymphoma (128)
Other Drugs Used for Chronic lymphocytic leukaemia
IBRUTINIB (37,003)
VENETOCLAX (14,194)
RITUXIMAB (7,231)
OBINUTUZUMAB (4,557)
ACALABRUTINIB (4,515)
IDELALISIB (3,537)
CYCLOPHOSPHAMIDE (3,085)
FLUDARABINE (2,777)
BENDAMUSTINE (2,561)
CHLORAMBUCIL (1,242)